 |
| Todd R. Golub, MD, Chair |
Director, Cancer Program, Broad Institute of MIT & Harvard, Cambridge, Massachusetts |
| Theodore S. Lawrence, MD, PhD, Vice-Chair |
University of Michigan Medical School, Ann Arbor, Michigan |
| Andrea Califano, PhD |
Professor of Systems Biology, Columbia University, New York, New York |
| Valerie Castle, MD |
University of Michigan, Ann Arbor, Michigan |
| David Eisenberg, PhD |
Investigator, HHMI, Professor Chemistry and Biochemistry, University of California, Los Angeles |
| Marilyn Hockenberry, PhD |
Duke University School of Nursing, Durham, North Carolina |
| William G. Kaelin, Jr., MD |
Dana-Farber Institute, Harvard Medical School, Howard Hughes Medical Institute, Boston, Massachusetts |
| Michael P. Link, MD |
Stanford University School of Medicine, Stanford, California |
| Eric G. Pamer, MD |
Memorial Sloan-Kettering Cancer Center, New York, New York |
| Charles L. Sawyers, MD |
Chief, Infectious Disease Service, Memorial Sloan-Kettering Cancer Center, New York, New York |
| William Sellers, MD |
Vice President and Global Head for Oncology, Novartis Institutes for BioMedical Research, Inc., Cambridge, Massachusetts |
| Paul M. Sondel, MD, PhD |
University of Wisconsin Medical School, Madison, Wisconsin |
| Louise C. Strong, MD |
U.T. M.D. Anderson Cancer Center, Houston, Texas |
 |